HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Guinan Selected Research

1,2-dielaidoylphosphatidylethanolamine (Lipofectin)

6/2012Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR.
9/2011Bax expression remains unchanged following antisense treatment directed against BCL-2.
12/2010Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick Guinan Research Topics

Disease

25Neoplasms (Cancer)
11/2015 - 01/2003
20Prostatic Neoplasms (Prostate Cancer)
11/2015 - 01/2003
3Breast Neoplasms (Breast Cancer)
09/2010 - 01/2008
1Lymphoma (Lymphomas)
11/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2015
1Carcinogenesis
01/2013
1Virus Diseases (Viral Diseases)
03/2011
1Glioblastoma (Glioblastoma Multiforme)
01/2008
1Communicable Diseases (Infectious Diseases)
01/2005

Drug/Important Bio-Agent (IBA)

25Antisense OligonucleotidesIBA
11/2015 - 01/2003
17Proteins (Proteins, Gene)FDA Link
11/2015 - 01/2005
9ErbB Receptors (EGF Receptor)IBA
01/2009 - 01/2003
7Transforming Growth Factor alpha (TGF-alpha)IBA
01/2009 - 01/2003
4AntigensIBA
11/2015 - 01/2005
4AndrogensIBA
09/2014 - 09/2012
4Paclitaxel (Taxol)FDA LinkGeneric
01/2009 - 01/2003
3OligonucleotidesIBA
11/2015 - 06/2007
3Androgen Receptors (Androgen Receptor)IBA
01/2013 - 01/2005
31,2-dielaidoylphosphatidylethanolamine (Lipofectin)IBA
06/2012 - 12/2010
3Prostate-Specific Antigen (Semenogelase)IBA
06/2007 - 05/2004
2Surface Antigens (Surface Antigen)IBA
06/2012 - 01/2011
2Messenger RNA (mRNA)IBA
01/2009 - 01/2003
2Hormones (Hormone)IBA
01/2006 - 01/2005
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
11/2015
1CyclinsIBA
11/2015
1Caspase 3 (Caspase-3)IBA
11/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2014
1Interleukin-6 (Interleukin 6)IBA
01/2013
1Interleukin-4 (Interleukin 4)IBA
09/2012
1Insulin-Like PeptidesIBA
09/2012
1Cancer VaccinesIBA
06/2012
1Antiviral Agents (Antivirals)IBA
03/2011
1VaccinesIBA
01/2011
1Differentiation AntigensIBA
01/2011
1CytokinesIBA
12/2010
1ClusterinIBA
09/2010
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2009
1Sirolimus (Rapamycin)FDA Link
01/2009
1Apoptosis Regulatory ProteinsIBA
01/2009
1Monoclonal AntibodiesIBA
06/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2005
1Small Interfering RNA (siRNA)IBA
07/2005
1Cisplatin (Platino)FDA LinkGeneric
07/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2005
1OligodeoxyribonucleotidesIBA
05/2004

Therapy/Procedure

6Therapeutics
03/2013 - 01/2004
1Combination Drug Therapy (Combination Chemotherapy)
01/2007
1Orchiectomy (Orchidectomy)
01/2005